Collegium Pharmaceuticalincis A Biopharmaceutical Company Based In Stoughtonmassachusettsfounded In 2014It Focuses On Developing And Commercializing Medications For Serious Medical Conditionsparticularly Chronic Pain And Attention Deficit Hyperactivity Disorderadhd The Company Employs Around 357 People And Reported Significant Revenue And Net Income Collegium Specializes In Innovative Drug Delivery Technologiesnotably Its Proprietary Deterx Platformwhich Allows For Extended Release Formulations With Abuse Deterrent Propertieskey Products Include Xtampza Eran Abuse Deterrent Oxycodone For Chronic Painand The Nucynta Portfoliowhich Offers Both Extended Release And Immediate Release Options For Pain Managementother Products Include Belbuca For Severe Painjornay Pm For Adhdand Symproic For Opioid Induced Constipationthe Company Is Committed To Responsible Opioid Stewardship And Community Health Initiativesaiming To Improve Well Being While Addressing Unmet Needs In Pain Management And Adhd Treatment
